Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC)

Neoadjuvant therapy (NAT) in breast cancer is administered to downstage the tumor, de-escalate surgery, and provide prognostic information that can be used to tailor subsequent adjuvant therapy. In this respect, the pathological evaluation of both pre-NAT biopsies and post-NAT surgical specimens is...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusco, Nicola, Rizzo, Antonio, Costarelli, Leopoldo, Santinelli, Alfredo, Cerbelli, Bruna, Scatena, Cristian, Macrì, Ettore, Pietribiasi, Francesca, d’Amati, Giulia, Sapino, Anna, Castellano, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore srl 2022
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248246/
https://www.ncbi.nlm.nih.gov/pubmed/35414722
http://dx.doi.org/10.32074/1591-951X-747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248246/
https://www.ncbi.nlm.nih.gov/pubmed/35414722
http://dx.doi.org/10.32074/1591-951X-747

Ejemplares similares